| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| Cost of Revenue | $0 | — | -100.0% |
| Gross Profit | $0 | — | -100.0% |
| R&D Expense | $24.5M | -7.8% | +41.6% |
| SG&A Expense | $9.1M | -32.9% | +7.8% |
| Operating Income | -$1.16B | -1177.1% | -2347.9% |
| Income Tax | -$1.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $229.3M | -19.3% | -40.6% |
| Current Assets | $369.6M | -9.5% | -34.5% |
| Total Assets | $629.9M | -64.8% | -73.0% |
| Current Liabilities | $22.3M | -46.7% | -17.2% |
| Total Liabilities | $47.4M | -19.6% | -47.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$93.0M | — | — |
| Capital Expenditures | $15.1M | — | — |
| Investing Cash Flow | -$6.7M | — | — |
| Financing Cash Flow | -$164K | — | — |
| Free Cash Flow | -$108.1M | — | — |
| +75.2% |
| Net Income | -$411.5M | -1362.2% | — |
| EPS (Basic) | -$5.28 | -1366.7% | — |
| EPS (Diluted) | -$5.28 | -1366.7% | — |
| $143.8M |
| -76.7% |
| -81.3% |